Reuters: Regulatory News: Bayer wins EU endorsement for Xarelto in lung embolism

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Bayer wins EU endorsement for Xarelto in lung embolism Oct 19th 2012, 12:28 FRANKFURT | Fri Oct 19, 2012 8:28am EDT FRANKFURT Oct 19 (Reuters) - German drugmaker Bayer said its Xarelto blood-thinning pill was recommended for approval by the European drugs regulator for the treatment of dangerous blood clots of the lung, a condition known as pulmonary embolism. Bayer also won an endorsement from watchdog European Medicines Agency (EMA) for the pill's use in preventing recurrent deep vein thrombosis - another form of blood clotting - Bayer said in a statement on Friday. EMA's guidance is usually followed by the EU Commission for its decisions on drug approvals.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions